Results 11 to 20 of about 28,723 (210)

Utilizing enoxaparin in the management of STEMI

Vascular Health and Risk Management, 2007
Andrea Rubboli1, Alessandro Capecchi2, Giuseppe Di Pasquale11Division of Cardiology, Maggiore Hospital, Bologna, Italy; 2Division of Cardiology, General Hospital, Bentivoglio, ItalyAbstract: The use of enoxaparin in conjunction with thrombolysis in ST ...
Andrea Rubboli, Alessandro Capecchi, Giuseppe Di Pasquale   +2 more
doaj   +1 more source

Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications

Clinical Pharmacology: Advances and Applications, 2018
Linda Tahaineh,1 Sahar M Edaily,1 Shadi F Gharaibeh2 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology (JUST), Irbid, Jordan; 2Department of Pharmaceutical Sciences, Faculty of Pharmacy, Jerash University,
Tahaineh L, Edaily SM, Gharaibeh SF
doaj   +1 more source

Update on the Pharmacological Actions of Enoxaparin in Nonsurgical Patients

Medicina
Low-molecular-weight heparins are a class of drugs derived from the enzymatic depolymerization of unfractionated heparin that includes enoxaparin. Several studies have been performed on enoxaparin in recent years, in particular for the prevention and ...
Egidio Imbalzano, Luana Orlando, Giuseppe Dattilo, Marianna Gigliotti De Fazio, Giuseppe Camporese, Vincenzo Russo, Alessandro Perrella, Francesca Futura Bernardi, Pierpaolo Di Micco   +8 more
doaj   +2 more sources

Effects of Enoxaparin Emulsion on Dimethylbenzanthracene-induced Breast Cancer in Female Rats

Research in Molecular Medicine, 2017
Background : Enoxaparin is an anticoagulant medication. Anticoagulation inhibits tumor cell–mediated release of angiogenic proteins and diminishes angiogenic response.
Moona Bolandpayeh, Hassanpour-Ezzati, Mousavi   +2 more
doaj   +1 more source

Enoxaparin pretreatment alleviates pentylenetetrazol–induced epileptic seizures in Wistar rats

Revista Científica
Epilepsy, is a prevalent neurological disorder characterized by recurring seizures. A low molecular weight heparin enoxaparin has multifaceted properties.
Huseyin Gungor, Nergiz Hacer Turgut
doaj   +2 more sources

Equivalence between branded enoxaparin and biosimilar enoxaparin.

, 2023
Equivalence between branded enoxaparin and biosimilar enoxaparin.
Chadli Dziri (14048856), Mehdi Khalfallah (17319734), Wafa Ben Hmida (17319731), Ibtissem Bouasker (17319743), Wejih Dougaz (7506221), Imen Samaali (17319737), Hichem Jerraya (17319740), Ramzi Nouira (17319746)   +7 more
core   +1 more source

Comparative study: Demographic variables (branded enoxaparin vs biosimilar enoxaparin groups).

, 2023
Comparative study: Demographic variables (branded enoxaparin vs biosimilar enoxaparin groups).
Chadli Dziri (14048856), Mehdi Khalfallah (17319734), Wafa Ben Hmida (17319731), Ibtissem Bouasker (17319743), Wejih Dougaz (7506221), Imen Samaali (17319737), Hichem Jerraya (17319740), Ramzi Nouira (17319746)   +7 more
core   +1 more source

Edoxaban: an update on the new oral direct factor Xa inhibitor. [PDF]

, 2014
Edoxaban is a once-daily oral anticoagulant that rapidly and selectively inhibits factor Xa in a concentration-dependent manner. This review describes the extensive clinical development program of edoxaban, including phase III studies in patients with ...
Camm, AJ, Bounameaux, H, A. John Camm, Henri Bounameaux   +3 more
core   +1 more source

Dosis Efektif Enoxaparin dalam Mencegah Terjadinya Trombosis pada Anastomosis Arteri Femoralis Tikus

JBN (Jurnal Bedah Nasional), 2017
Tujuan: untuk mengetahui dosis efektif enoxaparin dalam mencegah terjadinya trombosis pada anastomosis mikrovaskular. Metode: penelitian ini bersifat eksperimental dengan rancangan the randomized post test only control group design.
I Made Suka Adnyana, Iswinarno Doso Saputro   +1 more
doaj   +1 more source

Enoxaparin-induced reactive thrombocytosis: a case report

Thrombosis Journal, 2021
Background Enoxaparin is an anticoagulant that falls in the class of medications called low molecular weight heparins (LMWHs), and is used to prevent or treat patients with deep vein thrombosis (DVT) and pulmonary embolism.
Tao Xiang, Ming Cheng
doaj   +1 more source